Sandoz Group AG (MEX:SDZN) Shares Outstanding (EOP): 433 Mil (As of Dec. 2025)


MEX:SDZN Sandoz Group AG MEX:SDZN
16 GF Score
Price MXN1,481.70
! 6 Warning Signs
View Full Analysis

What is Sandoz Group AG Shares Outstanding (EOP)?

Sandoz Group AG MEX:SDZN 16 Shares Outstanding (EOP) is 433 Mil as of Dec. 2025. GuruFocus rates MEX:SDZN with a GF Score™ of 16/100. The stock has 6 warning signs investors should review.

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Sandoz Group AG's shares outstanding for the quarter that ended in Dec. 2025 was 433 Mil.

Sandoz Group AG's quarterly shares outstanding increased from Jun. 2025 (431 Mil) to Dec. 2025 (433 Mil). It means Sandoz Group AG issued new shares from Jun. 2025 to Dec. 2025 .

Sandoz Group AG's annual shares outstanding increased from Dec. 2024 (431 Mil) to Dec. 2025 (433 Mil). It means Sandoz Group AG issued new shares from Dec. 2024 to Dec. 2025 .


Sandoz Group AG  (MEX:SDZN) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Sandoz Group AG Shares Outstanding (EOP) Related Terms


Sandoz Group AG Shares Outstanding (EOP) Historical Data

* Premium members only.

The historical data trend for Sandoz Group AG's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sandoz Group AG Shares Outstanding (EOP) Chart

Sandoz Group AG Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Shares Outstanding (EOP)
431.00 429.93 430.70 432.69

Sandoz Group AG Semi-Annual Data
Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Shares Outstanding (EOP) Get a 7-Day Free Trial 429.93 438.93 430.70 430.70 432.69

MEX:SDZN vs ZTS, UTHR, VTRS: Shares Outstanding (EOP) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Sandoz Group AG's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sandoz Group AG Shares Outstanding (EOP) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sandoz Group AG's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where Sandoz Group AG's Shares Outstanding (EOP) falls into.


MEX:SDZN
16GF Score
Sandoz Group AG MEX:SDZN
Shares Outstanding (EOP) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sandoz Group AG Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (EOP) of 433 Mil mean?
Sandoz Group AG (MEX:SDZN) has a Shares Outstanding (EOP) of 433 Mil as of Dec. 2025. The total shares a company has outstanding, at period-end. View historical data on Sandoz Group AG and its competitors.
Is Sandoz Group AG's Shares Outstanding (EOP) too high?
Sandoz Group AG's current Shares Outstanding (EOP) is 433 Mil. Overall, Sandoz Group AG has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Sandoz Group AG's Shares Outstanding (EOP) compare to ZTS and UTHR?
Sandoz Group AG's Shares Outstanding (EOP) of 433 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (EOP) for a Drug Manufacturers company?
A good Shares Outstanding (EOP) depends on the Drug Manufacturers industry context. However, Shares Outstanding (EOP) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (EOP) mean?
A high Shares Outstanding (EOP) can signal that a stock is expensive relative to its fundamentals. The total shares a company has outstanding, at period-end. View historical data on Sandoz Group AG and its competitors. Sandoz Group AG's current Shares Outstanding (EOP) is 433 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sandoz Group AG stock overvalued right now?
Sandoz Group AG (MEX:SDZN) has a current Shares Outstanding (EOP) of 433 Mil. The current Shares Outstanding (EOP) is 433 Mil. Sandoz Group AG's overall GF Score™ is 16/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (EOP) calculated?
Shares Outstanding (EOP) is calculated from a company's financial statements. For Sandoz Group AG (MEX:SDZN), the current Shares Outstanding (EOP) is 433 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sandoz Group AG Business Description

Address Centralbahnstrasse 4, Basel, CHE, 4051
Sandoz is one of the largest generic pharmaceutical manufacturers in the world, generating over $11 billion annually from off-patent drugs. Once part of Novartis, Sandoz spun off and went public in October 2023. Generics, including small molecules and complex injectables, make up roughly 75% of Sandoz's total sales, and the firm has a significant presence in Europe, the United States, and other key international markets. Sandoz generates its remaining sales from biosimilars and is among the leaders in the space. Sandoz launched Europe's first biosimilar, Omnitrope, in 2006, as well as the first US biosimilar, Zarxio, in 2015. It has over 10 launched biosimilars in a number of markets and over 20 assets in its pipeline.
16GF Score

Get the complete analysis for MEX:SDZN

Shares Outstanding (EOP) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1,481.70
Price